33.20
전일 마감가:
$34.03
열려 있는:
$33.89
하루 거래량:
364.05K
Relative Volume:
0.54
시가총액:
$1.07B
수익:
$4.85M
순이익/손실:
$-114.75M
주가수익비율:
-10.22
EPS:
-3.25
순현금흐름:
$-100.36M
1주 성능:
-1.40%
1개월 성능:
-4.98%
6개월 성능:
+53.00%
1년 성능:
+17.40%
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
명칭
Dianthus Therapeutics Inc
전화
929-999-4055
주소
7 TIMES SQUARE, NEW YORK
DNTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DNTH
Dianthus Therapeutics Inc
|
33.20 | 1.35B | 4.85M | -114.75M | -100.36M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Truist | Buy |
| 2025-07-02 | 개시 | William Blair | Outperform |
| 2024-12-20 | 개시 | TD Cowen | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-26 | 개시 | Robert W. Baird | Outperform |
| 2024-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-16 | 개시 | H.C. Wainwright | Buy |
| 2024-02-15 | 개시 | Stifel | Buy |
| 2023-12-26 | 개시 | Jefferies | Buy |
| 2023-11-22 | 개시 | Wedbush | Outperform |
| 2023-10-30 | 개시 | Guggenheim | Buy |
| 2023-09-28 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-06 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-20 | 재개 | Goldman | Neutral |
| 2021-08-03 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-22 | 재확인 | B. Riley Securities | Buy |
| 2021-06-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-18 | 개시 | B. Riley Securities | Buy |
| 2021-01-07 | 개시 | Mizuho | Buy |
| 2020-06-08 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-03-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-03-15 | 개시 | Raymond James | Outperform |
모두보기
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
Dianthus Therapeutics to Participate in Four Investor Conferences During November - The Manila Times
Dianthus Therapeutics (Nasdaq: DNTH) plans CEO fireside chats at four November conferences - Stock Titan
How to monitor Dianthus Therapeutics Inc. with trend dashboardsBreakout Watch & Verified High Yield Trade Plans - newser.com
How forex fluctuations impact Dianthus Therapeutics Inc. (87E) stockWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
Smart tools for monitoring Dianthus Therapeutics Inc.’s price actionTrade Entry Summary & Entry Point Strategy Guides - newser.com
How Dianthus Therapeutics Inc. stock reacts to global recession fearsQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Is Dianthus Therapeutics Inc. (87E) stock a fit for income portfoliosJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
What dividend safety score for Dianthus Therapeutics Inc. stock2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Trend analysis for Dianthus Therapeutics Inc. this weekQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Using Python tools to backtest Dianthus Therapeutics Inc. strategiesEarnings Performance Report & Weekly Stock Performance Updates - newser.com
Dianthus Therapeutics Inc. stock chart pattern explainedWeekly Profit Summary & Weekly Momentum Picks - newser.com
Dianthus Therapeutics Reports Positive Phase 2 Results - TipRanks
Dianthus Therapeutics, Inc. Updates Corporate Presentation - TradingView
Will Dianthus Therapeutics Inc. stock see PE expansionWeekly Market Outlook & Daily Profit Focused Screening - newser.com
Why Dianthus Therapeutics Inc. stock remains resilientQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com
What recovery options are there for Dianthus Therapeutics Inc.July 2025 Final Week & Free Community Consensus Stock Picks - newser.com
Will Dianthus Therapeutics Inc. (87E) stock hit Wall Street targetsJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
How to escape a deep drawdown in Dianthus Therapeutics Inc.Gap Up & Growth Focused Stock Reports - newser.com
Will Dianthus Therapeutics Inc. (87E) stock gain from green policiesChart Signals & AI Enhanced Market Trend Forecasts - newser.com
Will Dianthus Therapeutics Inc. (87E) stock outperform value peersJuly 2025 Pullbacks & Daily Market Momentum Tracking - newser.com
Using Bollinger Bands to evaluate Dianthus Therapeutics Inc.2025 Macro Impact & Free Safe Capital Growth Stock Tips - newser.com
Long term hold vs stop loss in Dianthus Therapeutics Inc.2025 Momentum Check & Fast Moving Stock Watchlists - newser.com
Can Dianthus Therapeutics Inc. stock hit analyst price targetsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Dianthus Therapeutics, Inc. (DNTH) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Using economic indicators to assess Dianthus Therapeutics Inc. potentialWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
Dianthus Therapeutics (DNTH) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
What to expect from Dianthus Therapeutics Inc. in the next 30 daysJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Dianthus Therapeutics Inc (DNTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):